DRKS00026956已完成不适用
COVAG study - COVID 19 Antigen Study - COVAG study
Synlab Academy, Synlab Holding Deutschland GmbH0 个研究点目标入组 3,733 人开始时间: 2021年10月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 3,733
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Subjects eligible for inclusion in this study must meet the following criteria:
- •1. Signed informed consent must be obtained prior to study participation. The patient must be capable of understanding the nature, significance and implication of the trial.
- •2. Age 18 years or more
排除标准
- •1. Lack of informed consent
- •2. Inability to understand the nature, significance and implication of the trial.
- •3. Severe clinical conditions requiring emergency hospitalization
- •4. Children and adolescents under the age of 18 years
研究者
相似试验
尚未招募
不适用
COVID-19 Contact Vaccine StudyCOVID-19U07.1COVID-19, virus identifiedDRKS00023972Medizinische Hochschule Hannover1,000
已完成
不适用
COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection TestsCOVID-19SARS-CoV2 InfectionSARS (Disease)NCT05074017Synlab Holding Deutschland GmbH2,222
尚未招募
不适用
Pilot study to analyze COVID-19 vaccination responseM05Seropositive rheumatoid arthritisDRKS00024787Medizinische Klinik 3, Universitätsklinikum Erlangen60
已完成
不适用
Research for acquired immunity according to COVID-19 vaccinatioCOVID-19JPRN-UMIN000043340Keio University600
已完成
不适用
Observational study on the evaluation of COVID-19 prevention and subjects' health status after SARS-CoV-2 vaccinatioCOVID-19JPRN-UMIN000045107Shionogi & Co., Ltd.829